chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She had not had the same ankle problem, knee problem and hip problem that was affecting her walk until the first and second day of the first shot; She had not had the same ankle problem, knee problem and hip problem that was affecting her walk until the first and second day of the first shot; She had not had the same ankle problem, knee problem and hip problem that was affecting her walk until the first and second day of the first shot; Driveway at the steering wheel with no memory; This is a spontaneous report from a contactable consumer. A 81-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number was not reported), dose 1 via an unspecified route of administration, administered in Arm Right on 15May2021 as DOSE 1, SINGLE for covid-19 immunisation. Medical history included pancreatic failure, Exocrine pancreatic insufficiency started maybe 8 months before she ever got the Pfizer vaccine, weight decreased, osteopenia (she has osteopenia as of 4 years ago), pneumonia cryptococcal (dormant Cryptococcus in her lungs), allergy to animal (allergic to pigeon, bat, and bird poop that gets into her system and gives her cryptococcus), lactose intolerance, rhinitis allergic, upper-airway cough syndrome, joint injury (ankle injury) and (knee injury). The patient's concomitant medications were not reported. The patient experienced she had not had the same ankle problem, knee problem and hip problem that was affecting her walk until the first and second day of the first shot and driveway at the steering wheel with no memory on an unknown date 2021. She had not had the same ankle problem, knee problem and hip problem that was affecting her walk until the first and second day of the first shot. This re-developed after the Pfizer shot. Evidently her first shot was 15 May 2021. She believes she reported in her original report, that she came back from her brothers which is over 12 miles away the second day after the first shot or the second shot, maybe it was the second shot. She knows she reported this information in the original report, but she woke up in her driveway at the steering wheel with no memory of how she got home. She was the driver with no passengers. She doesn't remember if this happened with the first shot or second shot, but she reported this particular problem of how she had no recollection of how she got home. The clinical outcome of the event was unknown. Investigation Assessment was provided as no.   The lot number for [BNT162B2], was not provided and will be requested during follow up.
Clinic calls varicella illness 6/9/03 after having been vaccinated (8/2/01).
Achy Joints, Cold and hot at the same time, headache on 1-10-2021 from 2am until 2pm. Took Aleve at 10am
her lips and inside of her mouth started to swell; her lips and inside of her mouth started to swell/ just looked like I had lip fillers; she felt an itching sensation in her mouth; This is a spontaneous report from a contactable consumer (Patient).  The female patient received first dose of BNT162B2 (Pfizer Covid-19 vaccine, solution for injection, Lot number: unknown) via an unspecified route of administration on 01Apr2021 as a single dose for Covid-19 immunization. Medical history included anaphylactic reactions to animal products. She's wondering why she responded to the vaccine this way. Concomitant medications were not reported. On 01Apr2021 within 10 minutes after first dose, her lips and inside of her mouth started to swell and resolved within 20 minutes of the shot. On 01Apr2021, she felt an itching sensation in her mouth. It was stated that her symptoms were never really bad, just looked like she had lip fillers and it was never escalated to an emergency situation. It was stated that she was scheduled for second dose a day next to this report. The outcome of the events was recovered on 01Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained
Two hours post injection, I start to feel slightly unwell which progressed rapidly to flu-like symptoms.  By 7:00PM on 4/1/2021, I have a temperature of 99.2 and significant arthralgia., injection site discomfort, H.A..  By 5:30AM, temperature had risen to 99.7F.  At that time I took 400mg of ibupropfen.  Temperature was reduced to 99.2.  Low grade fever and body pain lasted approximately 30-35 hours. I still having lingering nausea.
Started showing symtpoms of odynophagia (pain in swallowing) on 19Jan2021; Had ulcerative pharyngitis; clean based yellow ulcers on tonsillar beds bilaterally; This is a spontaneous report from a non-contactable consumer. A 31-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 16Jan2021 at a single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. It was reported that the patient started showing symptoms of odynophagia (pain in swallowing) on 19Jan2021. The patient also experienced ulcerative pharyngitis, clean based yellow ulcers on tonsillar beds bilaterally. No purulent discharge, no lymphadenopathy, no angioedema, mon screen negative, COVID screen negative, strep throat negative, viral panel negative on an unspecified date. The patient was hospitalized for 2 days due to the events. The patient received treatment for the events. The outcome of the events was unknown.  Information on the Lot/Batch number has been requested.
Pfizer vaccine injected 3:00 PM  3/10/21.  The next day, 27 hours post-vaccine injection, while in a store, patient noted at 6:06 PM onset of numbness/tingling Right foot/leg with difficulty standing/lifting foot.  He needed support of shopping cart to make it to car.  Once in car, numbness/tingling, heaviness/clumsiness of right hand/arm noted.  Then right side of lips/mouth affected with dysarthria.  Wife witnessed evolution and drove directly to Hospital ER/stroke center by which time patient was vomiting and required wheelchair to enter ER.  Stroke team evaluation neurologist concluded ischemic stroke and administered TPA.  During TPA infusion, all symptoms resolved remarkably so that dysarthria cleared, numbness resolved and dysmetria/fine motor incoordination/right hand/arm/leg/foot symptoms were markedly improved.  Patient admitted to ICU for one day and then neurocare floor for one day.  MRI showed 8 mm linear diffusion weighted lesion in right centrum semiovale which was deemed c/w acute/subacute infarct.  Attending neurologist in ICU and neurofloor noted that location laterality of MRI lesion did not correlate well with the right-sided patient symptoms, but could not identify other left brain lesions on review of scans.  EKG, TEE and echo studies showed no cardiac lesions.  Carotid studies were negative.  CT and CT angio were uninformative;  no hemorrhagic lesions or large vessel blockage.  At discharge on 3/14/2021 around 6 PM,  patient could walk, talk, and use hands essentially normally to outside observer although patient could relate intermittent brief episodes of possible numbness in lips or hands/fingers or slight heaviness of foot which is slight and decreasing.  Patient discharged on atorvastatin, amlodipine, fluticasone, Loratadine, 81 mg aspirin, Ibuprofen (for headaches) for further post-stroke follow-up.
16Jan98 Pt recv 1 dose vax. 27Jan98 pt devel "one pox-like area on chin". 28Jan98 Pt devel fever,fatigue & itching inject site,face, back,trunk & backs of legs.15 pox-like marks. 02Feb98 Pt devel crusting on chin rash. 04Feb98 Pt recovered.
An employee felt heart palpitation after her 2nd shot of Pfizer. We took her blood pressure reading and it was normal, then  told her to rest more, drink fluid.  Then 5-10 minutes later, she felt itchiness on her right leg.  I checked and it was red and had 2 bumpy spots from her scratches. We gave her diphenhydramine 50mg/ml with 1 ml IM.  I told her to rest and warned her of drowsiness.  After 5 minutes, she started feeling better wanted to leave (used uber) before she get too drowsy.
Patient reported feeling feverish and chills 1 hour following flu immunization. Patient denied rash, hives, tightness in throat or trouble breathing. RN monitored vitals and completed a physical assessment. RN suggested patient remain in the area if she wanted to, or said she could go back to her work area. Contact physician if symptoms persist.
PATIENT FAINTED, THEN WAS ALERT & ORIENTED. THEY SAID THEY HAVE A PMH OF SYNCOPY & THIS HAPPENS APPROXIMATELY ONCE A MONTH. PARAMEDICS WERE CALLED. NO ISSUES WITH RESPIRATION.
This spontaneous report as received from a Licensed Practical Nurse refers to a patient of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On an unknown date, the patient was vaccinated with PNEUMOVAX23 (dose, route and frequency were not reported). Other suspect therapies included GARDASIL and PEDVAXHIB. On an unknown date, an improperly stored PNEUMOVAX23, GARDASIL, and PEDVAXHIB that was exposed to a temperature of 33F for an unspecified amount of time had been administered. PNEUMOVAX23, GARDASIL, and PEDVAXHIB had been stored at 34F for "years" because her clinic was under the impression by the Vaccines for Children Program (VFC) that 34F was proper storage range for the PNEUMOVAX23, GARDASIL, and PEDVAXHIB. The nurse stated that "other" clinics in her area were also under the impression that 34F is proper storage range for "refrigerated vaccines". No adverse effect was reported. Additional information has been requested.
Off-site clinics were being conducted & the staff was not monitoring vaccine temperatures; first dose was on 30-NOV-2021 and second dose was on 11-JAN-2022; There were also 10 underage recipients; Off-site clinics were being conducted & the staff was not monitoring vaccine temperatures; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Off-site clinics were being conducted & the staff was not monitoring vaccine temperatures), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (There were also 10 underage recipients), POOR QUALITY PRODUCT ADMINISTERED (Off-site clinics were being conducted & the staff was not monitoring vaccine temperatures) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was on 30-NOV-2021 and second dose was on 11-JAN-2022) in a 15-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Nov-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (There were also 10 underage recipients) and POOR QUALITY PRODUCT ADMINISTERED (Off-site clinics were being conducted & the staff was not monitoring vaccine temperatures). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Off-site clinics were being conducted & the staff was not monitoring vaccine temperatures) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was on 30-NOV-2021 and second dose was on 11-JAN-2022). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Off-site clinics were being conducted & the staff was not monitoring vaccine temperatures), PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (There were also 10 underage recipients), POOR QUALITY PRODUCT ADMINISTERED (Off-site clinics were being conducted & the staff was not monitoring vaccine temperatures) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (first dose was on 30-NOV-2021 and second dose was on 11-JAN-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant product use was provided.  Storage condition at the time of the excursion: Refrigerated.  Excursion duration was unknown (12Jan2021- 22Apr2022).  No treatment medication was provided.
Patient came in with complaints of red swollen arm. On exam patient shows symptoms of red, warm, erythematous upper arm, swollen deltoid consistent with histamine reaction (left upper arm).
Less than 24 hours after getting the vacc. pt. developed a fever (101 degrees), vacc. site became swollen & achy, pt. had gen. flu-like sx. Pt. used BENADRYL q 6 hours & ADVIL q 4 hours to help with sx. Pt. also applied ice to her arm. Pt. took BENADRYL prior to receiving the vacc. d/t a similar reaction about 10 yrs. ago. Arm discomfort lasted 1 wk.
Had headache and dizziness  in the next 24 hrs after the 2nd dose lasted for 3 days which is much worse than from the first dose symptoms. Then after a week experience shortness of breath in the morning and at night when asleep. Continue for more than two weeks and gradually become every other day then once a week. Saw my doctor and had some test done, xray, stress test. No significant findings. Noticed to get short of breath easily compared last year on same activity.
pt recv vax & that evening, pain, swollen feeling rt arm, rt middle finger palm w/rt hand;2-3 days later pain in lateral jaw so couldn't open mouth to eat;pain in lt hand, lt knee;12 days later still c/o pain lt hand, although better today;
Severe headache since onset time and continues now (11:10 PM). (Headaches are extremely rare for me).
itching; arm swollen; red arm; itchy arm; scratching the insides of her hands and wrists; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), VACCINATION SITE SWELLING (arm swollen), VACCINATION SITE ERYTHEMA (red arm), VACCINATION SITE PRURITUS (itchy arm) and SCRATCH (scratching the insides of her hands and wrists) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.    Co-suspect product included non-company product COLLAGEN for an unknown indication.    Concomitant products included OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), HYDROCODONE BITARTRATE, PARACETAMOL (VICODIN), AMLODIPINE, GABAPENTIN, amour thryoid, FLUOXETINE HYDROCHLORIDE (PROZAC), CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID), MAGNESIUM and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started COLLAGEN (unknown route) dosage form. On 05-Apr-2021, the patient experienced PRURITUS (itching), VACCINATION SITE SWELLING (arm swollen), VACCINATION SITE ERYTHEMA (red arm), VACCINATION SITE PRURITUS (itchy arm) and SCRATCH (scratching the insides of her hands and wrists). At the time of the report, PRURITUS (itching), VACCINATION SITE SWELLING (arm swollen), VACCINATION SITE ERYTHEMA (red arm), VACCINATION SITE PRURITUS (itchy arm) and SCRATCH (scratching the insides of her hands and wrists) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included,Cortisone and Neosporin with no alleviation
Pentacel was given too early. Patient needed a plain Polio and a plain Haemophilus Influenzae.
Hive rash on face, neck, upper limbs, hands, below the knees, lower back, scalp, noticed rash at 730am on 1/10/2019 and estimate it started around 5am judging by speed of growth.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality. The reporter is the patient.  A 73-year-old male patient received BNT162b2 (BNT162B2), on 18Jan2021 at 13:00 as dose 1, single (Lot number: EL8982), in left arm, on 08Feb2021 as dose 2, single (Batch/Lot number: unknown), in left arm, on 05Oct2021 as dose 3 (booster), single (Lot number: 30146BA), in left arm and on 14Apr2022 as dose 4 (booster), single (Lot number: 9729) at the age of 73 years, in left arm for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 06Jun2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (06Jun2022) Positive, notes: antigen tests Abbot BinaxNOW very strong positive result; (12Jun2022) Positive, notes: very weak positive antigen test; (15Jun2022) Positive, notes: strong positive antigen test. Therapeutic measures were taken as a result of vaccination failure, covid-19.No known allergies and other medical history reported for the patient.   Clinical course: Drug Fluticasone started on 23May2022 and stopped on 6Jun2022. Lot number (ab4318a).  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Patient states arm has been very sore and she has limited mobility in the vaccinated arm since receiving the vaccine. Sates that she has tried ibuprofen and ice and nothing has helped it is getting worse.
Within about 3hs had reaction (light fever, chills, wheezing, developing into tachycardia). Rxn started 3hrs after vaccine progressed over 1/2 - 1 hr, high blood pressure (189/100+). Gave IV CARDIZEM, breathing treatment, prednisone.
Patient was seen for 1 month physical. Patient was due to receive Hepatitis B vaccine. Medical assistant administered Meningococcal B (TRUMEMBA) vaccine in error. Baby developed fever approx. 13 hours later, sleepy, poor feeding. T 103.3. Admitted to Hospital.
Closed left hip fracture, Syncope, & Hypoxia. The patient tolerated the surgical procedure without complications and was hospitalized for a total of 8 nights following the surgical procedure. The hospitalization was necessary for pain control, therapy, medical care and discharge placement. Ultimately, the patient was discharged to skilled nursing facility under satisfactory medical and post-operative condition. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
Vaccine Administration Error - Patient moved while Dtap was being administered and did not receive a full dose due to the needle coming back out (25Gx1) ; patient also moved while Polio was being administered and did not receive a full dose due to the needle bending (retractable Vanish Point needle). The vaccines are normally given together in a combination vaccine (Kinrix) at 4 years old, but we were out of stock for that vaccine. Patient received full Dtap dose in left deltoid with assistance and full Polio dose in the right deltoid with assistance.
The vial was initially stored in the refrigerator on 12-Oct-2022 and administered on 14-Nov-2022; No adverse event; Received expired Bivalent Booster  after 30-day Use By Date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received expired Bivalent Booster  after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 12-Oct-2022 and administered on 14-Nov-2022) and NO ADVERSE EVENT (No adverse event) in a 12-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 030G22B) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 14-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received expired Bivalent Booster  after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 12-Oct-2022 and administered on 14-Nov-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received expired Bivalent Booster  after 30-day Use By Date), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 12-Oct-2022 and administered on 14-Nov-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Received expired Bivalent Booster  after 30-day Use By Date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 12-Oct-2022 and administered on 14-Nov-2022).    No concomitant medication details was reported. It was reported that individual vial from an open Box was used. Vial size was reported as 2.5 ml. The vial was initially stored in the refrigerator on 12-OCT-2022. Beyond use date was 11-NOV-2022. The vial did not undergo any temperature excursions. No treatment medication details was reported.
One hour after vaccine patient complains of nausea, fever, chills, diarrhea, myalgias and arthralgias. Presented to Dr on 6/19 for evaluation. Recommended pretreat with Ibuprofen and/or BENADRYL prior to next dose.
With the 1st Dose, my right arm hurt for a whole month. With the 2nd Dose, I did not have any symptoms and my arm did not hurt. When I was using  a push mower, and I'm a barber, I noticed I had to stop, because I was feeling tired. Then I noticed the left side of my neck and shoulder blade had a sore spot and while I had been working on my weed eater. I went to my chiropractor and massage therapist. I just so happen to have a heart attack after the 3rd visit. I was taking my wife to work, I did not feel good, I was nauseated and had dizziness and I went back to my house to lay down. And after that I don't remember getting out of the truck. I hit my head on the cement and received a concussion, my wife told me. I don't remember any of it.  I had to stay 2 extra days in the hospital because of the concussion. On 06/07/2021, Hospital,  I had a heart attack in my front yard. The treatment they put in stents. They installed prox RCA was 4 mm by 23mm , and the 2nd stent distal circ 2.25mm by 18 mm. It was Abbott vascular and the XIENCE sierra. I am still  recovering, I have 14 weeks of cardiac therapy. I have to take extra medicine Plavix , 81 mg baby aspirin , Atorvastatin,  Clopidogrel od, metoprolol tartrate od,  about 5 new medications to keep my stents from plugging up. I used to be able to do the elliptical for like 45 minutes now I can barely do 5 minutes. I am not the same guy with the same energy as I was.
Generalized weakness, in the hospital about 3 weeks ago for a GI and cardiac work-up, 10 days ago she tested positive for Covid but her only symptoms were worsening of her nausea and vomiting, increasing shortness of breath on exertion, chest pain with activity and has been unable to keep down any food or drink.  She does endorse some falls over the past few weeks where her "legs give out" due to weakness.